×
Zevia PBC Income Taxes 2021-2024 | ZVIA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Zevia PBC income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
View More
Zevia PBC Income Taxes 2021-2024 | ZVIA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Zevia PBC income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$205.5B
Stryker (SYK)
$138.7B
Boston Scientific (BSX)
$121.5B
Medtronic (MDT)
$113.7B
EssilorLuxottica (ESLOY)
$104.2B
Haleon (HLN)
$48.6B
Lonza Group Ag (LZAGY)
$45.9B
ResMed (RMD)
$36.9B
Koninklijke Philips (PHG)
$29.3B
Terumo (TRUMY)
$27.8B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$20.3B
Insulet (PODD)
$16.5B
Smith & Nephew SNATS (SNN)
$13.5B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$9.2B
BellRing Brands (BRBR)
$7.7B
Lantheus Holdings (LNTH)
$7.3B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$3.9B
TG Therapeutics (TGTX)
$3.9B
GN Store Nord (GNNDY)
$3.8B
Perrigo (PRGO)
$3.8B
Neogen (NEOG)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Envista Holdings (NVST)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Maravai LifeSciences Holdings (MRVI)
$2.3B
Green Thumb Industries (GTBIF)
$2.2B